These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16101820)

  • 1. Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.
    Zhao Y; van Kessel KPM; de Haas CJC; Rogers MRC; van Strijp JAG; Haas PA
    Cell Microbiol; 2018 Nov; 20(11):e12941. PubMed ID: 30098280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview.
    Rabiet MJ; Huet E; Boulay F
    Biochimie; 2007 Sep; 89(9):1089-106. PubMed ID: 17428601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
    Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
    Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
    Matron C; Chakravarti A; Allaeys I; Poubelle PE
    Free Radic Biol Med; 2010 Jan; 48(2):207-15. PubMed ID: 19854263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
    Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of formyl peptide receptor signaling by peptide ligands.
    Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
    Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways.
    Boxio R; Bossenmeyer-Pourié C; Vanderesse R; Dournon C; Nüsse O
    Scand J Immunol; 2005 Aug; 62(2):140-7. PubMed ID: 16101820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.
    Selvatici R; Falzarano S; Mollica A; Spisani S
    Eur J Pharmacol; 2006 Mar; 534(1-3):1-11. PubMed ID: 16516193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
    Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
    Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WKYMVm Works by Targeting Immune Cells.
    Yang Y; Zhao J; Jiang C; Zhang Y; Han M; Liu H
    J Inflamm Res; 2023; 16():45-55. PubMed ID: 36636250
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.